Latest News about IDRA
Recent news which mentions IDRA
56 Stocks Moving In Thursday's Mid-Day Session
Today 12:09 EDT
From Benzinga
60 Biggest Movers From Yesterday
September 16, 2020
From Benzinga
42 Stocks Moving In Tuesday's Mid-Day Session
September 15, 2020
From Benzinga
61 Biggest Movers From Yesterday
August 26, 2020
From Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
August 25, 2020
From Benzinga
70 Biggest Movers From Yesterday
July 22, 2020
From Benzinga
56 Stocks Moving In Tuesday's Mid-Day Session
July 21, 2020
From Benzinga
45 Stocks Moving in Tuesday's Pre-Market Session
July 21, 2020
From Benzinga
77 Biggest Movers From Yesterday
July 21, 2020
From Benzinga
58 Stocks Moving In Monday's Mid-Day Session
July 20, 2020
From Benzinga
36 Stocks Moving in Monday's Pre-Market Session
July 20, 2020
From Benzinga
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
April 26, 2020
From Benzinga
86 Biggest Movers From Yesterday
April 09, 2020
From Benzinga
65 Stocks Moving In Wednesday's Mid-Day Session
April 08, 2020
From Benzinga
The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
April 08, 2020
From Benzinga
30 Stocks Moving in Wednesday's Pre-Market Session
April 08, 2020
From Benzinga
6 Stocks Moving In Tuesday's After-Hours Session
April 07, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 16, 2020
From Benzinga
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
March 12, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 11, 2020
From Benzinga
From Benzinga
98 Biotechnology Stocks Moving In Wednesday's Session
January 22, 2020
From Benzinga
82 Biggest Movers From Yesterday
January 22, 2020
From Benzinga
55 Stocks Moving In Tuesday's Mid-Day Session
January 21, 2020
From Benzinga
The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
December 17, 2019
From Benzinga
The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer
December 13, 2019
From Benzinga
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
December 12, 2019
From Benzinga
The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
December 11, 2019
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 10, 2019
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.